Benjamin Besse

*This is an algorithmically generated author record based on publicly available information.

Research Subjects

Lung Cancer

Research Interests

Benjamin Besse has a total of 811 co-authors. Here are the top co-authors by number of shared publications:

D. Planchard
Medical Oncology, Gustave Roussy, Villejuif/FR
11 shared publications
Jean Charles Soria
Department of Drug Development, Institut Gustave Roussy, Villejuif, France
10 shared publications
L. Lacroix
Translational Research Laboratory, Gustave Roussy, Villejuif/FR
10 shared publications
C. Caramella
Radiology Department, Gustave Roussy, Villejuif/FR
9 shared publications
J. Adam
Pathology Department, Gustave Roussy, Villejuif/FR
9 shared publications
J. Soria
Drug Development Department, Gustave Roussy, Villejuif/FR
9 shared publications

Latest Publications

Sort by

Website
Google Scholar
- 1 January 2018
- Published by Elsevier in Revue des Maladies Respiratoires
Effet anti-tumoral d’une héparine de bas poids moléculaire dans le cancer bronchique localisé : l’essai Tinzaparin In Lung Tumors (TILT)
by P. Girard, B. Besse, H. Doubre, A. Charles-Nelson, S. Aquilanti, A. Izadifar, R. Azarian, I. Monnet, C. Lamour, R. Descourt, et al.
Website
Google Scholar
- 1 January 2018
- Published by Elsevier in Revue des Maladies Respiratoires
Effet anti-tumoral d’une héparine de bas poids moléculaire dans le cancer bronchique localisé : l’essai Tinzaparin In Lung Tumors (TILT)
by P. Girard, B. Besse, H. Doubre, A. Charles-Nelson, S. Aquilanti, A. Izadifar, R. Azarian, I. Monnet, C. Lamour, R. Descourt, et al.
Website
Google Scholar
Cited by 11
- 1 November 2017
- Published by Elsevier in Journal of Thoracic Oncology
P2.07-005 Impact of Baseline Leptomeningeal and Brain Metastases on Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
by C. Henon, L. Mezquita, E. Auclin, S. Ammari, C. Caramella, C. Le Pechoux, A. Botticella, D. Planchard, A. Gazzah, R. Ferrara, et al.
Website
Google Scholar
- 1 November 2017
- Published by Elsevier in Journal of Thoracic Oncology
P2.07-005 Impact of Baseline Leptomeningeal and Brain Metastases on Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
by C. Henon, L. Mezquita, E. Auclin, S. Ammari, C. Caramella, C. Le Pechoux, A. Botticella, D. Planchard, A. Gazzah, R. Ferrara, et al.
Cited by 11
Website
Google Scholar
- 1 November 2017
- Published by Elsevier in Journal of Thoracic Oncology
P1.03-013 Monitoring of ALK Fusions and Mutations in Advanced ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
by L. Mezquita, J. Remon, C. Nicotra, M. Noerholm, K. Brinkmann, D. Planchard, C. Jovelet, E. Auclin, C. Flinspach, J. Hurley, et al.
Website
Google Scholar
- 1 November 2017
- Published by Elsevier in Journal of Thoracic Oncology
P1.03-013 Monitoring of ALK Fusions and Mutations in Advanced ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
by L. Mezquita, J. Remon, C. Nicotra, M. Noerholm, K. Brinkmann, D. Planchard, C. Jovelet, E. Auclin, C. Flinspach, J. Hurley, et al.
Website
Google Scholar
- 1 November 2017
- Published by Elsevier in Journal of Thoracic Oncology
P2.07-060 Response Assessment and Subgroups Analysis According to the Lung Immune Prognostic Index (LIPI) for Immunotherapy in Advanced NSCLC Patients
by L. Mezquita, E. Auclin, R. Ferrara, C. Caramella, M. Charrier, J. Remon, D. Planchard, S. Ponce, L. Paz-Ares, J. Lahmar, et al.
Website
Google Scholar
- 1 November 2017
- Published by Elsevier in Journal of Thoracic Oncology
P2.07-060 Response Assessment and Subgroups Analysis According to the Lung Immune Prognostic Index (LIPI) for Immunotherapy in Advanced NSCLC Patients
by L. Mezquita, E. Auclin, R. Ferrara, C. Caramella, M. Charrier, J. Remon, D. Planchard, S. Ponce, L. Paz-Ares, J. Lahmar, et al.
Website
Google Scholar
- 1 November 2017
- Published by Elsevier in Journal of Thoracic Oncology
P2.01-038 Determinants of Frailty and Treatment Toxicity in Non-Small Cell Lung Cancer Patient
by M. Boucher, L. Mezquita, E. Auclin, M. Mons, J. Marghadi, M. Charrier, R. Ferrara, D. Planchard, G. Anas, C. Le Pechoux, et al.
Website
Google Scholar
- 1 November 2017
- Published by Elsevier in Journal of Thoracic Oncology
P2.01-038 Determinants of Frailty and Treatment Toxicity in Non-Small Cell Lung Cancer Patient
by M. Boucher, L. Mezquita, E. Auclin, M. Mons, J. Marghadi, M. Charrier, R. Ferrara, D. Planchard, G. Anas, C. Le Pechoux, et al.
Website
Google Scholar
- 11 October 2016
- Published by Elsevier in Annals of Oncology
Genomic profile in pulmonary neuroendocrine tumors (puNETs): the whole-exome sequencing (WES) as a strategic tool
by I.G. Sullivan, M. Deloger, L. Lacroix, B. Job, N. Dorvault, J. Adam, A. Honore, L. Gianoncelli, G. Le Teuff, V. de Montpreville, et al.
Website
Google Scholar
- 11 October 2016
- Published by Elsevier in Annals of Oncology
Genomic profile in pulmonary neuroendocrine tumors (puNETs): the whole-exome sequencing (WES) as a strategic tool
by I.G. Sullivan, M. Deloger, L. Lacroix, B. Job, N. Dorvault, J. Adam, A. Honore, L. Gianoncelli, G. Le Teuff, V. de Montpreville, et al.
Website
Google Scholar
Cited by 1
- 1 September 2015
- Published by Elsevier in European Journal of Cancer
3104 Rociletinib treatment and outcomes in non-small cell lung cancer (NSCLC) patients with negative central testing for T790M
by B. Solomon, H. Wakelee, L.V. Sequist, S. Gadgeel, J.C. Soria, J.W. Goldman, H. Yu, D.R. Camidge, V. Papadimitrakopoulou, S. Matheny, et al.
Website
Google Scholar
- 1 September 2015
- Published by Elsevier in European Journal of Cancer
3104 Rociletinib treatment and outcomes in non-small cell lung cancer (NSCLC) patients with negative central testing for T790M
by B. Solomon, H. Wakelee, L.V. Sequist, S. Gadgeel, J.C. Soria, J.W. Goldman, H. Yu, D.R. Camidge, V. Papadimitrakopoulou, S. Matheny, et al.
Cited by 1
Website
Google Scholar
Cited by 5
- 1 September 2015
- Published by Elsevier in European Journal of Cancer
3025 Prognostic value of PDL1 expression in stage III Non-Small Cell Lung Cancer (NSCLC) treated by chemo-radiotherapy (CRT)
by J. Adam, A. Boros, B. Lacas, L. Lacroix, J.P. Pignon, C. Caramella, D. Planchard, A. Levy, B. Besse, C. Le Pechoux
Website
Google Scholar
- 1 September 2015
- Published by Elsevier in European Journal of Cancer
3025 Prognostic value of PDL1 expression in stage III Non-Small Cell Lung Cancer (NSCLC) treated by chemo-radiotherapy (CRT)
by J. Adam, A. Boros, B. Lacas, L. Lacroix, J.P. Pignon, C. Caramella, D. Planchard, A. Levy, B. Besse, C. Le Pechoux
Cited by 5
Website
Google Scholar
Cited by 2
- 1 September 2015
- Published by Elsevier in European Journal of Cancer
467 Radiomics to identify HER2 amplification or mutation in metastatic patients with solid tumors prospectively enrolled in MOSCATO-01
by E.R. Haspinger, S. Rosellini, S. Ammari, L. Dercle, M.V. Bluthgen, B. Besse, C. Caramella, C. Massard, L. Lacroix, T. De Baere, et al.
Website
Google Scholar
- 1 September 2015
- Published by Elsevier in European Journal of Cancer
467 Radiomics to identify HER2 amplification or mutation in metastatic patients with solid tumors prospectively enrolled in MOSCATO-01
by E.R. Haspinger, S. Rosellini, S. Ammari, L. Dercle, M.V. Bluthgen, B. Besse, C. Caramella, C. Massard, L. Lacroix, T. De Baere, et al.
Cited by 2
Website
Google Scholar
Cited by 7
- 1 September 2015
- Published by Elsevier in European Journal of Cancer
3133 Prognostic value of texture analysis and correlation with molecular profile in EGFR mutated/ALK rearranged advanced non-small cell lung cancer (NSCLC)
by C. Caramella, M.V. Bluthgen, S. Rosellini, C. Leduc, F. Facchinetti, E. Haspinger, C. Ferte, S. Michiels, J.C. Soria, B. Besse
Website
Google Scholar
- 1 September 2015
- Published by Elsevier in European Journal of Cancer
3133 Prognostic value of texture analysis and correlation with molecular profile in EGFR mutated/ALK rearranged advanced non-small cell lung cancer (NSCLC)
by C. Caramella, M.V. Bluthgen, S. Rosellini, C. Leduc, F. Facchinetti, E. Haspinger, C. Ferte, S. Michiels, J.C. Soria, B. Besse
Cited by 7

Show all